Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-056086

See Remarks acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhode Peter See Remarks 2023-11-17 Option exercise +15,000 $0.14 $2,100 63,500 D
Derivatives
Rhode Peter See Remarks 2023-11-17 Option exercise · Stock Option Grant (Right to Buy) −15,000 36,427 D
Loading xslF345X05/doc4.xml…